Prognostic Implications of Vancomycin Therapeutic Drug Monitoring for Critically Ill Stroke Patients: Evidence From a Subtype‐Oriented Analysis

Post‐stroke infections, particularly those caused by Gram‐positive pathogens, are frequent in neurocritical care and worsen outcomes. Vancomycin is widely used against severe Gram‐positive infections, and therapeutic drug monitoring (TDM) is recommended to optimize efficacy and minimize toxicity. However, its prognostic value in critically ill stroke patients remains unclear.